LobbyingInflarx Pharmaceuticals lobbying by quarter
Inflarx Pharmaceuticals's latest lobbying report covers Q2 2025, at under $5,000. Its first report covers Q3 2023; the issues it reports most are Health Issues.
Inflarx Pharmaceuticals
- Latest quarter
- No record
- Q2 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q2 2026 against the quarter before
- First report
- Q3 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q3 2023 | $20K | 1 |
| Q4 2023 | $20K | 1 |
| Q1 2024 | $10K | 1 |
| Q2 2024 | $0 | 1 |
| Q3 2024 | $0 | 1 |
| Q4 2024 | $0 | 1 |
| Q1 2025 | $0 | 1 |
| Q2 2025 | $0 | 1 |
| Q3 2025 | $0 | 0 |
| Q4 2025 | $0 | 0 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
Policy issues the reports name
- Health issues6 reports
A report that names several issues counts once for each.
Who was lobbied
- Natl Institutes of Health (NIH)6 reports
- SENATE6 reports
Firms it paid
| Firm | ||
|---|---|---|
| Faegre Drinker Biddle & Reath | $50K | 8 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/07/17for Q2 2025 | Faegre Drinker Biddle & Reath | Under $5,000 |
| 25/07/17for Q2 2025 | Faegre Drinker Biddle & Reath | Under $5,000 |
| 25/04/18for Q1 2025 | Faegre Drinker Biddle & Reath | Under $5,000 |
| 25/01/17for Q4 2024 | Faegre Drinker Biddle & Reath | Under $5,000 |
| 24/10/21for Q3 2024 | Faegre Drinker Biddle & Reath | Under $5,000 |
| 24/07/22for Q2 2024 | Faegre Drinker Biddle & Reath | Under $5,000 |
| 24/04/19for Q1 2024 | Faegre Drinker Biddle & Reath | $10K |
| 24/01/22for Q4 2023 | Faegre Drinker Biddle & Reath | $20K |
| 23/10/20for Q3 2023 | Faegre Drinker Biddle & Reath | $20K |
| 23/10/20for Q3 2023 | Faegre Drinker Biddle & Reath | Under $5,000 |